Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supporting Material
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carter, O.
Right arrow Articles by Dashwood, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carter, O.
Right arrow Articles by Dashwood, R. H.
© 2004 The American Society for Nutritional Sciences J. Nutr. 134:3441S-3444S, December 2004


Supplement: International Research Conference on Food, Nutrition, and Cancer

The Dietary Phytochemical Chlorophyllin Alters E-Cadherin and ß-Catenin Expression in Human Colon Cancer Cells1,3

Orianna Carter, George S. Bailey and Roderick H. Dashwood4

Linus Pauling Institute, Oregon State University, Corvallis, OR 97331

4To whom correspondence should be addressed. E-mail: Rod.Dashwood{at}oregonstate.edu.

Chlorophyllin (CHL), an anticarcinogenic and antimutagenic water-soluble derivative of chlorophyll, has been reported to induce apoptosis in human colon cancer cells via a pathway involving cell differentiation. Induction of differentiation markers may be important in limiting cancer-cell invasion and metastasis, and there is much interest in understanding the underlying mechanisms, because this might provide insights for cancer chemotherapy. In the present study, human HCT116 colon-cancer cells were treated with CHL, and the expression levels of E-cadherin and ß-catenin were examined using immunocytochemistry and laser scanning confocal microscopy. E-cadherin was detected almost exclusively at the cell periphery of cancer cells treated with or without CHL, but the expression of E-cadherin in the plasma membrane was markedly elevated in the cells treated with CHL. ß-Catenin also was strongly expressed in the plasma membrane, especially after CHL treatment. No change in the expression of ß-catenin mRNA was detected across a broad range of CHL concentrations (10–500 µmol/L), but there was a concentration-dependent decrease in nuclear ß-catenin protein levels without overt changes in the cytosolic pool of ß-catenin. Our interpretation of these findings is that CHL induces E-cadherin expression, and this facilitates trafficking of ß-catenin away from the nucleus and into the plasma membrane, possibly for destruction via the adherins junction remodeling (Hakai) pathway.


KEY WORDS: • colon cancer • chemoprevention • adherins junctions




This article has been cited by other articles:


Home page
CarcinogenesisHome page
G. Calviello, F. Resci, S. Serini, E. Piccioni, A. Toesca, A. Boninsegna, G. Monego, F. O. Ranelletti, and P. Palozza
Docosahexaenoic acid induces proteasome-dependent degradation of {beta}-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2
Carcinogenesis, June 1, 2007; 28(6): 1202 - 1209.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2004 by American Society for Nutrition